Adia Nutrition (ADIA) Cash from Operations (2025 - 2026)
Adia Nutrition's (ADIA) quarterly Cash from Operations came in at -$55037.0 in Q1 2026, down 76.54% year-over-year from -$234620.3 in Q1 2025, and down 76.54% quarter-over-quarter from -$31175.0 in Q1 2025.
Powered by 
Analysis
Adia Nutrition (ADIA) Cash from Operations (2025 - 2026) Analysis & Trends
Adia Nutrition (ADIA) has reported Cash from Operations for 2 consecutive years, with -$55037.0 the latest figure, recorded in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 9.96 Bn | 9.12 Bn | 112.79 Mn | 74.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.47 Bn | 5.47 Bn | - | -83.50 Mn |
| 3 | Iovance Biotherapeutics | 4.64 Bn | 4.35 Bn | 55.72 Mn | -60.82 Mn |
| 4 | Legend Biotech | 3.25 Bn | 2.28 Bn | 251.50 Mn | -20.90 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | -28.58 Mn |
| 6 | Precigen | 2.79 Bn | 2.79 Bn | 52.17 Mn | -17.81 Mn |
| 7 | Beam Therapeutics | 2.58 Bn | 2.58 Bn | - | -66.10 Mn |
| 8 | Sarepta Therapeutics | 2.12 Bn | 1.33 Bn | 251.87 Mn | 197.07 Mn |
| 9 | Vericel | 2.05 Bn | 1.89 Bn | 56.40 Mn | 16.19 Mn |
| 10 | Adia Nutrition | 11.33 Mn | 11.33 Mn | - | - |